Rafferty Asset Management LLC Buys 15,747 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Rafferty Asset Management LLC increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 74.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,839 shares of the biotechnology company's stock after purchasing an additional 15,747 shares during the period. Rafferty Asset Management LLC's holdings in Axon Enterprise were worth $21,894,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of AXON. Artemis Investment Management LLP lifted its holdings in Axon Enterprise by 21.4% in the 4th quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company's stock worth $56,528,000 after purchasing an additional 16,792 shares during the last quarter. Decker Retirement Planning Inc. bought a new stake in shares of Axon Enterprise during the 4th quarter worth $2,985,000. Perigon Wealth Management LLC acquired a new position in Axon Enterprise in the 4th quarter valued at $488,000. Hennion & Walsh Asset Management Inc. raised its holdings in Axon Enterprise by 26.8% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 7,169 shares of the biotechnology company's stock worth $4,261,000 after acquiring an additional 1,517 shares during the period. Finally, Geneos Wealth Management Inc. boosted its holdings in Axon Enterprise by 630.0% during the fourth quarter. Geneos Wealth Management Inc. now owns 1,847 shares of the biotechnology company's stock valued at $1,098,000 after acquiring an additional 1,594 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AXON has been the subject of several research analyst reports. Needham & Company LLC boosted their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. The Goldman Sachs Group upped their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Barclays boosted their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Finally, JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $652.73.

Axon Enterprise Price Performance

AXON traded up $4.79 on Friday, reaching $733.18. The stock had a trading volume of 419,101 shares, compared to its average volume of 759,084. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $735.68. The firm has a 50-day moving average of $584.61 and a 200-day moving average of $595.70. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $57.08 billion, a price-to-earnings ratio of 189.45, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business's quarterly revenue was up 31.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.15 earnings per share. As a group, sell-side analysts anticipate that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 23,764 shares of company stock worth $14,856,635 in the last 90 days. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.